Summary of IOPA Activities

IOPA was established in 2017 to engage with opioid manufacturers, distributors, and retail pharmacies on opioid-related business risks that have implications for long-term shareholders, communities, and the economy. In 2023, the IOPA wound down its collaborative efforts. In its five years of operations, the coalition actively engaged numerous corporate boards and executives in dialogue, filed more than a hundred shareholder proposals, and took on the most important governance reforms within major pharmaceutical companies to better manage societal and enterprise risks.